Cardinal Health, Inc. (CAH) FY2024 Annual P&L / Income Statement

Cardinal Health, Inc. (CAH) FY2024 Annual P&L / Income Statement

Income statement for 2023-07-01 through 2024-06-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenue

226,827,000,000 US dollars

Cost of products sold

219,413,000,000 US dollars

Gross margin

7,414,000,000 US dollars

Operating costs, including other operating expenses (calculated)

6,171,000,000 US dollars

Operating earnings/(loss)

1,243,000,000 US dollars

Other income (expense), net (calculated)

negative 42,000,000 US dollars

Earnings/(loss) before income taxes

1,201,000,000 US dollars

Provision for income taxes

348,000,000 US dollars

Net earnings/(loss)

853,000,000 US dollars

Non-US

1,681,000,000 US dollars

UNITED STATES

225,231,000,000 US dollars

Distribution, selling, general and administrative expenses

5,000,000,000 US dollars

Restructuring and employee severance

175,000,000 US dollars

Amortization and other acquisition-related costs

284,000,000 US dollars

Impairments and (gain)/loss on disposal of assets, net

634,000,000 US dollars

Litigation (recoveries)/charges, net

78,000,000 US dollars

Revenue before reconciliation (calculated)

226,912,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Components above reported revenue (calculated)

negative 85,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
• Of which attributable to Cardinal Health, Inc.: $852.00 M; to noncontrolling interests: $1.00 M.